Results 161 to 170 of about 2,847,157 (340)

Continuous quality improvement of colorectal cancer screening

, 2013
Mariusz Madaliński
openalex   +2 more sources

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund, Johan Reutfors, Thomas Frisell, Fredrik Piehl   +3 more
wiley   +1 more source

Continuous improvement towards environmental protection for pharmaceuticals: advancing a strategy for Europe. [PDF]

Environ Sci Eur
Harrison S, Barnett C, Short S, Uluseker C, Silva PV, Pavlaki MD, Roberts S, Vieira M, Lofts S, Loureiro S, Spurgeon DJ.   +10 more
europepmc   +1 more source

Commentary: Semper ad meliora: Continuous improvement in enhanced recovery pathways. [PDF]

JTCVS Open, 2022
Delman AM, Van Haren RM.
europepmc   +1 more source

Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang, Lu Lu, Hui Gao, Qi Zhang, Jing Xiao, Josemir W. Sander, Weixi Xiong, Dong Zhou   +7 more
wiley   +1 more source

Continuous Improvement of Frontal Rhytids Following Glabella Only Treatments With Neuromodulators-A Clinical Prospective Pilot Study. [PDF]

J Cosmet Dermatol
Munoz-Lora VRM, Rogerio V, Thiesen V, Carnevali ACN, Bravo C, Shridharani SM, Eccleston D, Alfertshofer M, Germani M, Cotofana S.   +9 more
europepmc   +1 more source

Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew, Maryam Kargaran, Maik Rothe, Andreas Deistung, Dietrich Stoevesandt, Walter A. Wohlgemuth, David Strube, Thomas Kendzierski, Anna Katharina Kölsch, Maurits Gerhard Abraham Heuschen, Markus Otto, Alexander Mensch   +11 more
wiley   +1 more source

Implementing the Chinese mandatory antimicrobial stewardship program: barriers to continuous improvement. [PDF]

Health Policy Plan
Wang X, Lin L, Xu X, Harbarth S, Yakob L, Zhang R, Zhou X.   +6 more
europepmc   +1 more source

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang, Jianli Zhao, Xue Zhao, Xiaowei Hu, Zichun Xiao, Jie Wu, Xiaowen Li, Jing Xu, Yu‐Jing Li   +8 more
wiley   +1 more source

Bend the Curve CIP-News - October, 2006 [PDF]

, 2006
Bend the Curve Continuous Improvement Practitioners
core   +9 more sources